Carlsmed (CARL) Operating Leases (2024 - 2026)

Carlsmed (CARL) has reported Operating Leases for 3 consecutive years, with $5.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Leases rose 242.05% year-over-year to $5.8 million; the trailing twelve-month figure through Jun 2026 stood at $5.8 million (up 242.05% YoY), and the FY2025 full-year result was $1.3 million, changed 0.08% from the prior year.
• Operating Leases climbed to $5.8 million in Q2 2026 per CARL's latest filing, from $1.1 million in the prior quarter.
• Across five years, Operating Leases topped out at $5.8 million in Q2 2026 and bottomed at $1.1 million in Q1 2026.
• Historically, Operating Leases has averaged $2.1 million across 3 years, with a median of $1.4 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Operating Leases retreated 0.08% in 2025, then jumped 242.05% in 2026.
• Over 3 years, Operating Leases stood at $1.3 million in 2024, then dropped by 0.08% to $1.3 million in 2025, then surged by 343.16% to $5.8 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $5.8 million, $1.1 million, and $1.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.